Helping advance meaningful policy change on heart failure
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma.
The content produced by the Network is not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members, who have full editorial control. All members provide their time for free.Find out more